Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

Kalemkerian Gregory P.; Narula Navneet; Kennedy Erin B.; Biermann William A.; Donington Jessica; Leighl Natasha B.; Lew Madelyn; Pantelas James; Ramalingam Suresh S.; Reck Martin; Saqi Anjali; Simoff Michael; Singh Navneet; Sundaram Baskaran

首页> 外文期刊>Journal of Clinical Oncology >Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

【24h】

Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

机译：用于选择肺癌患者靶向酪氨酸激酶抑制剂的分子检测指南：美国病理学家临床肿瘤学会的认可/分子病理学临床实践指南更新的肺癌/国际肺癌研究协会

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2018年第9期|共11页
作者
Kalemkerian Gregory P.; Narula Navneet; Kennedy Erin B.; Biermann William A.; Donington Jessica; Leighl Natasha B.; Lew Madelyn; Pantelas James; Ramalingam Suresh S.; Reck Martin; Saqi Anjali; Simoff Michael; Singh Navneet; Sundaram Baskaran;
展开▼
作者单位

Univ Michigan Ann Arbor MI 48109 USA;

Weill Cornell Med Coll New York NY USA;

Amer Soc Clin Oncol 2318 Mill Rd Suite 800 Alexandria VA 22314 USA;

Chestnut Hill Hosp East Norriton PA USA;

NYU Sch Med New York NY USA;

Princess Margaret Canc Ctr Toronto ON Canada;

Univ Michigan Ann Arbor MI 48109 USA;

Greater Detroit Area Detroit MI USA;

Emory Univ Winship Canc Inst Atlanta GA 30322 USA;

Lung Clin Grosshansdorf Grosshansdorf Germany;

Columbia Univ Med Ctr New York NY USA;

Henry Ford Hosp Detroit MI 48202 USA;

Postgrad Inst Med Educ &

Res Chandigarh India;

Thomas Jefferson Med Sch Philadelphia PA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update [J] . Kalemkerian Gregory P., Narula Navneet, Kennedy Erin B., Journal of Clinical Oncology . 2018,第9期

机译：用于选择肺癌患者靶向酪氨酸激酶抑制剂的分子检测指南：美国病理学家临床肿瘤学会的认可/分子病理学临床实践指南更新的肺癌/国际肺癌研究协会
2. Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the college of American pathologists/international association for the study of lung cancer/association for molecular pathology guideline [J] . LeighlN.B., RekhtmanN., BiermannW.A., Journal of Clinical Oncology . 2014,第32期

机译：为肺癌患者选择表皮生长因子受体和间变性淋巴瘤激酶酪氨酸激酶抑制剂的分子测试：美国临床肿瘤学会认可的美国病理学家学院/国际肺癌研究协会/分子病理学协会联合会
3. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology [J] . Lindeman Neal I., Cagle Philip T., Aisner Dara L., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第3期

机译：更新的分子检测指南，用于选择肺癌患者的肺癌患者，靶向酪氨酸激酶抑制剂来自美国病理学家学院，国际肺癌研究协会和分子病理学协会
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. The cost effectiveness of screening for early stage lung cancer and the testing and treatment of molecular subgroups among non-small cell lung cancer patients in the province of ontario, canada [D] . Thao, Mallory. 2014

机译：加拿大安大略省非小细胞肺癌患者早期肺癌筛查的成本效益及分子亚群的检测和治疗
6. Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline [O] . Natasha B. Leighl, Natasha Rekhtman, William A. Biermann, -1

机译：为表皮生长因子受体和间变性淋巴瘤激酶酪氨酸激酶抑制剂选择肺癌患者的分子检测：美国病理学家学院/国际肺癌研究协会/分子病理学协会国际临床病理学会认可
7. Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline [O] . Natasha B. Leighl, Natasha Rekhtman, William A. Biermann, 2014

机译：对表皮生长因子受体和血吸虫淋巴瘤激酶酪氨酸激酶抑制剂选择肺癌患者的分子检测：美国病理学家临床肿瘤学会的认可/国际肺癌/分子病理学指南研究血阶癌症学会协会

摘要

著录项

相似文献

相关主题

期刊订阅